Phase III, Study of Three Short Course Combo (Ambisome®, Miltefosine, Paromomycin) Compared With AmBisome for the Treatment of VL in Bangladesh
Clinical trial NCT01122771 · COMPLETED
Trial details
- NCT number
- NCT01122771
- Sponsor
- Drugs for Neglected Diseases
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Primary completion
- 2014-03-01
- Enrollment
- 602
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.